LeukemiaNCT00056069
Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia
A study testing questionnaire administration in people with Leukemia, run by Children's Oncology Group at 122 sites in 6 countries.
Trial summary
RATIONALE: Studying the physical and emotional needs of parents who are caring for children receiving chemotherapy for cancer may help doctors plan effective treatments for the patient that allow for improved quality of life of the patient's family. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Leukemia
- What is being tested?
- questionnaire administration
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 172 participants
- Where
- 122 sitesin 6 countries
- Study dates
- Dec 2002to Mar 2010
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
DISEASE CHARACTERISTICS:
- Parent or legal guardian who is the primary caregiver of a patient enrolled on COG-P9904 or COG-P9905 protocol
- Patient has not yet received week 13 of therapy
PATIENT CHARACTERISTICS:
Age
- Not specified
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
Other
- Able to understand English
PRIOR CONCURRENT THERAPY:
Biologic therapy
- Not specified
Chemotherapy
- Not specified
Endocrine therapy
- Not specified
Radiotherapy
- Not specified
Surgery
- Not specified
Trial locations and contacts
122 sites in 6 countries.
122 sites in 6 countries
United States107 sites
University of New Mexico Cancer Research and Treatment Center
Albuquerque, New Mexico, 87131
Mission Hospitals - Memorial Campus
Asheville, North Carolina, 28801
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus
Atlanta, Georgia, 30342
MBCCOP-Medical College of Georgia Cancer Center
Augusta, Georgia, 30912-4000
Greenebaum Cancer Center at University of Maryland Medical Center
Baltimore, Maryland, 21201-1595
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231-7223
Pediatric Specialty Clinic at Eastern Maine Medical Center
Bangor, Maine, 04401
Comprehensive Cancer Center at University of Alabama at Birmingham
Birmingham, Alabama, 35233
Floating Hospital for Children
Boston, Massachusetts, 02111
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114-2696
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts, 02115
Vermont Cancer Center at University of Vermont
Burlington, Vermont, 05401-3498
Hollings Cancer Center at Medical University of South Carolina
Charleston, South Carolina, 29425-0721
West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division
Charleston, West Virginia, 25302
Blumenthal Cancer Center at Carolinas Medical Center
Charlotte, North Carolina, 28232-2861
Presbyterian Cancer Center at Presbyterian Hospital
Charlotte, North Carolina, 28233
University of Virginia Cancer Center
Charlottesville, Virginia, 22908
Rush University Medical Center
Chicago, Illinois, 60612
Children's Memorial Hospital - Chicago
Chicago, Illinois, 60614
University of Missouri - Columbia
Columbia, Missouri, 65203
Driscoll Children's Hospital
Corpus Christi, Texas, 78466
Medical City Dallas Hospital
Dallas, Texas, 75230
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Dallas, Texas, 75390-9063
Children's Hospital of Michigan
Detroit, Michigan, 48201
Van Elslander Cancer Center at St. John Hospital and Medical Center
Detroit, Michigan, 48236
Duke Comprehensive Cancer Center
Durham, North Carolina, 27710
INOVA Fairfax Hospital
Falls Church, Virginia, 22042-3300
Hurley Medical Center
Flint, Michigan, 48503
Broward General Medical Center Cancer Center
Fort Lauderdale, Florida, 33316
Children's Hospital of Southwest Florida
Fort Myers, Florida, 33908
Cook Children's Medical Center - Fort Worth
Fort Worth, Texas, 76104
University of Florida Shands Cancer Center
Gainesville, Florida, 32610-0296
University of Texas Medical Branch
Galveston, Texas, 77555-0209
St. Vincent Hospital
Green Bay, Wisconsin, 54307-9070
Leo W. Jenkins Cancer Center at Pitt County Memorial Hospital
Greenville, North Carolina, 27858-4354
Children's Hospital of Greenville Hospital System
Greenville, South Carolina, 29605
Hackensack University Medical Center
Hackensack, New Jersey, 07601
Joe DiMaggio Children's Hospital at Memorial
Hollywood, Florida, 33021
Cancer Research Center of Hawaii
Honolulu, Hawaii, 96813
Tripler Army Medical Center
Honolulu, Hawaii, 96859-5000
Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital
Houston, Texas, 77030-2399
University of Mississippi Medical Center
Jackson, Mississippi, 39216-4505
Nemours Children's Clinic
Jacksonville, Florida, 32207
East Tennessee State University Cancer Center at Johnson City Medical Center
Johnson City, Tennessee, 37614-0622
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, 66160-7357
Keesler Medical Center - Keesler Air Force Base
Keesler Air Force Base, Mississippi, 39534-2511
Rebecca and John Moores UCSD Cancer Center
La Jolla, California, 92093-0658
Wilford Hall Medical Center
Lackland Air Force Base, Texas, 78236-5300
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205
CCOP - Marshfield Clinic Research Foundation
Marshfield, Wisconsin, 54449
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105
University of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, 30101
Miami Children's Hospital
Miami, Florida, 33155
Baptist-South Miami Regional Cancer Program
Miami, Florida, 33176-2197
Midwest Children's Cancer Center
Milwaukee, Wisconsin, 53226
University of South Alabama Cancer Research Institute
Mobile, Alabama, 36604
Mary Babb Randolph Cancer Center at West Virginia University Hospitals
Morgantown, West Virginia, 26506-9300
Yale Comprehensive Cancer Center at Yale University School of Medicine
New Haven, Connecticut, 06520-8064
Schneider Children's Hospital
New Hyde Park, New York, 11040
MBCCOP - LSU Health Sciences Center
New Orleans, Louisiana, 70112
Tulane Cancer Center at Tulane University Hospital and Clinic
New Orleans, Louisiana, 70112
Children's Hospital of New Orleans
New Orleans, Louisiana, 70118
Ochsner Cancer Institute at Ochsner Clinic Foundation
New Orleans, Louisiana, 70121
Mount Sinai Medical Center
New York, New York, 10029
Beth Israel Medical Center - Singer Division
New York, New York, 10128
Advocate Hope Children's Hospital
Oak Lawn, Illinois, 60453
Oklahoma University Medical Center
Oklahoma City, Oklahoma, 73104
Florida Hospital Cancer Institute
Orlando, Florida, 32804
Nemours Children's Clinic - Orlando
Orlando, Florida, 32806
Stanford Cancer Center at Stanford University Medical Center
Palo Alto, California, 94304-1812
Sacred Heart Children's Hospital
Pensacola, Florida, 32504
Saint Jude Midwest Affiliate
Peoria, Illinois, 61637
St. Christopher's Hospital for Children
Philadelphia, Pennsylvania, 19134-1095
CCOP - Columbia River Oncology Program
Portland, Oregon, 97225
Legacy Emanuel Hospital and Health Center & Children's Hospital
Portland, Oregon, 97227
Naval Medical Center - Portsmouth
Portsmouth, Virginia, 23708-5100
Rhode Island Hospital
Providence, Rhode Island, 02903
Massey Cancer Center at Virginia Commonwealth University
Richmond, Virginia, 23298-0121
Carilion Medical Center for Children at Roanoke Community Hospital
Roanoke, Virginia, 24029
James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, 14642
Sutter Cancer Center
Sacramento, California, 95816
University of California Davis Cancer Center
Sacramento, California, 95817
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78207
MBCCOP - South Texas Pediatrics
San Antonio, Texas, 78229-3900
Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego
San Diego, California, 92120
Children's Hospital and Health Center - San Diego
San Diego, California, 92123-4282
Kaiser Permanente Medical Center - Santa Clara Kiely Campus
Santa Clara, California, 95051
Maine Children's Cancer Program
Scarborough, Maine, 04074-9308
Walter Reed Army Medical Center
Silver Spring, Maryland, 20910
Cardinal Glennon Children's Hospital
St Louis, Missouri, 63104
St. Louis Children's Hospital
St Louis, Missouri, 63110
All Children's Hospital
St. Petersburg, Florida, 33701
Long Island Cancer Center at Stony Brook University Hospital
Stony Brook, New York, 11794-8174
SUNY Upstate Medical University Hospital
Syracuse, New York, 13210
Madigan Army Medical Center
Tacoma, Washington, 98431-0001
St. Joseph's Children's Hospital of Tampa
Tampa, Florida, 33677-4227
CCOP - Scott and White Hospital
Temple, Texas, 76508
Center for Cancer Prevention and Care at Scott and White Clinic
Temple, Texas, 76508
Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, 85724
Natalie Warren Bryant Cancer Center at St. Francis Hospital
Tulsa, Oklahoma, 74136
Kaplan Cancer Center at St. Mary's Medical Center
West Palm Beach, Florida, 33407
CCOP - Wichita
Wichita, Kansas, 67214-3882
Via Christi Cancer Center at Via Christi Regional Medical Center
Wichita, Kansas, 67214
Wesley Medical Center
Wichita, Kansas, 67214
Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, 27157-1081
UMASS Memorial Cancer Center - University Campus
Worcester, Massachusetts, 01655
Canada8 sites
Alberta Children's Hospital
Calgary, Alberta, T2T 5C7
Cross Cancer Institute at University of Alberta
Edmonton, Alberta, T6G 1Z2
McMaster Children's Hospital at Hamilton Health Sciences
Hamilton, Ontario, L8S 4J9
Montreal Children's Hospital at McGill University Health Center
Montreal, Quebec, H3H 1P3
Hopital Sainte Justine
Montreal, Quebec, H3T 1C5
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1
Centre de Recherche du Centre Hospitalier de l'Universite Laval
Sainte-Foy, Quebec, GIV 4G2
Hospital for Sick Children
Toronto, Ontario, M5G 1X8
Australia3 sites
Royal Children's Hospital
Brisbane, Queensland, 4029
Royal Children's Hospital
Parkville, Victoria, 3052
Children's Hospital at Westmead
Westmead, New South Wales, 2145
Switzerland2 sites
Swiss Pediatric Oncology Group Bern
Bern, CH 3010
Swiss Pediatric Oncology Group Geneva
Geneva, CH 1211
About this study
Official title: Differences in Parental Caregiving Demands in Childhood Acute Lymphoblastic Leukemia by Length of Infusion Therapy
RATIONALE: Studying the physical and emotional needs of parents who are caring for children receiving chemotherapy for cancer may help doctors plan effective treatments for the patient that allow for improved quality of life of the patient's family.
PURPOSE: This clinical trial is studying the different physical and emotional needs of parents whose children are undergoing chemotherapy for acute lymphoblastic leukemia either in an outpatient clinic or in the hospital.
Read the detailed description
OBJECTIVES:
- Compare the caregiving demands reported by parents of children with acute lymphoblastic leukemia receiving methotrexate on 2 different infusion schedules (inpatient care vs outpatient care).
- Compare the change in caregiving demands on these parents over time, in terms of physical and emotional care, the need to make family arrangements, the need to communicate about the child's care, the need to gather information about the child's health status, and the effect on family well-being.
OUTLINE: Participants complete questionnaires regarding caregiver demands and family information over 25-30 minutes within 3-4 months of the initiation of the child's treatment and at the completion of the first year of the child's treatment.
PROJECTED ACCRUAL: A total of 164 participants will be accrued for this study within 0.8 years.
- Conditions
- Leukemia
- Being tested
- questionnaire administration
- Keywords
- psychosocial effects of cancer and its treatment, childhood acute lymphoblastic leukemia
- Medical subject headings
- Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
questionnaire administrationOther
Also called Ancillary studies
Participants complete questionnaires regarding caregiver demands and family information over 25-30 minutes within 3-4 months of the initiation of the child's treatment and at the completion of the first year of the child's treatment.
| Study group | Role | What they receive |
|---|---|---|
| Observational | Experimental | Questionnaire Administration: Participants complete questionnaires regarding caregiver demands and family information over 25-30 minutes within 3-4 months of the initiation of the child's treatment and at the completion of the first year of the child's treatment. Receives: Other: questionnaire administration |
What is being measured
The primary outcome is the main question the study is designed to answer.
Event Free Survival
Measured: Length of study
Secondary outcomes (2)
Determine whether caregivers whose child is randomized to receive the 24-hour methotrexate infusion will report lower caregiving demand than will caregivers whose child is randomized to receive the 4-hour infusion
Measured: Length of study
Total score from the CMCC
Measured: Length of study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Mar 2003 (estimated)
- Study startDec 2002
- Primary completionJan 2010
- Study completionMar 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for LeukemiaStudies of the same condition, open and under way.
- More trials run by Children's Oncology GroupThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 172 participants (actual)
Sponsor and investigators
- Lead sponsor
- Children's Oncology Group
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- Responsible party
- Sponsor
- Investigators
- Diane Keegan Wells, RN, MSN, CPNP, Study chair, University of Maryland Greenebaum Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00056069
- Sponsor's protocol ID
- ACCL01P3
- Other IDs
- COG-ACCL01P3, CDR0000271934, NCI-2012-02522, U10CA095861
- Status last verified
- May 2015
- First submitted
- 6 Mar 2003
- Last updated
- 7 May 2015
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 May 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Differences in Parental Caregiving Demands in Childhood Acute Lymphoblastic Leukemia by Length of Infusion Therapy
- ClinicalTrials.gov ID
- NCT00056069
- Acronym / sponsor ID
- ACCL01P3
- Conditions
- Leukemia
- Keywords
- psychosocial effects of cancer and its treatment, childhood acute lymphoblastic leukemia
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 172 participants (actual)
- Lead sponsor
- Children's Oncology GroupResearch network
- Collaborators
- National Cancer Institute (NCI)
- Study start
- Dec 2002
- Primary completion
- Jan 2010 (actual)
- Study completion
- Mar 2010 (actual)
- First posted
- 7 Mar 2003 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
RATIONALE: Studying the physical and emotional needs of parents who are caring for children receiving chemotherapy for cancer may help doctors plan effective treatments for the patient that allow for improved quality of life of the patient's family.
PURPOSE: This clinical trial is studying the different physical and emotional needs of parents whose children are undergoing chemotherapy for acute lymphoblastic leukemia either in an outpatient clinic or in the hospital.
Detailed description
OBJECTIVES:
- Compare the caregiving demands reported by parents of children with acute lymphoblastic leukemia receiving methotrexate on 2 different infusion schedules (inpatient care vs outpatient care).
- Compare the change in caregiving demands on these parents over time, in terms of physical and emotional care, the need to make family arrangements, the need to communicate about the child's care, the need to gather information about the child's health status, and the effect on family well-being.
OUTLINE: Participants complete questionnaires regarding caregiver demands and family information over 25-30 minutes within 3-4 months of the initiation of the child's treatment and at the completion of the first year of the child's treatment.
PROJECTED ACCRUAL: A total of 164 participants will be accrued for this study within 0.8 years.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Observational | Experimental | Other: questionnaire administrationQuestionnaire Administration: Participants complete questionnaires regarding caregiver demands and family information over 25-30 minutes within 3-4 months of the initiation of the child's treatment and at the completion of the first year of the child's treatment. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| questionnaire administrationAlso: Ancillary studiesParticipants complete questionnaires regarding caregiver demands and family information over 25-30 minutes within 3-4 months of the initiation of the child's treatment and at the completion of the first year of the child's treatment. | Other | Observational |
Primary outcome
Event Free Survival
Time frame: Length of study
2 secondary outcomes
Determine whether caregivers whose child is randomized to receive the 24-hour methotrexate infusion will report lower caregiving demand than will caregivers whose child is randomized to receive the 4-hour infusion
Time frame: Length of study
Total score from the CMCC
Time frame: Length of study
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 May 2015.
Related trials for Leukemia
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingPhase 1
A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML
AML (Acute Myeloid Leukemia)
RecruitingPhase 1
Vididencel in CML-CP Patients With MRD
CML (Chronic Myelogenous Leukemia)
RecruitingPhase 2
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Diane Keegan Wells, RN, MSN, CPNP study chair
University of Maryland Greenebaum Cancer Center
122 sites in 6 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing questionnaire administration in people with Leukemia, run by Children's Oncology Group at 122 sites in 6 countries.
The full registered description is in the About this study section and the official record.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 May 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 122 sites in United States, Canada, Australia, Switzerland, Netherlands and 1 more country. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Event Free Survival (time frame: Length of study). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2015.